Antipsychotic dopamine receptor antagonists, cancer, and cancer stem cells

Area of Science:

• Oncology
• Pharmacology
• Cancer Biology

Background:

• Metastatic cancers present significant therapeutic challenges due to drug resistance.
• Cancer stem cells (CSCs) are implicated in cancer recurrence and treatment failure.
• Existing therapeutic strategies often fail to effectively target CSCs.

Purpose of the Study:

• To review current strategies for targeting cancer stem cells (CSCs).
• To explore the potential of dopamine receptor (DR) antagonists in cancer therapy.
• To highlight the efficacy of antipsychotic DR antagonists in sensitizing CSCs to chemotherapy.

Main Methods:

• Review of existing literature on CSCs and their role in cancer.
• Analysis of studies investigating dopamine receptors (DRs) in various cancer types.
• Examination of research on antipsychotic DR antagonists and their mechanism of action on CSCs.

Main Results:

• Dopamine receptors (DRs) are frequently found in diverse cancer types.
• Antipsychotic DR antagonists demonstrate significant ability to restrain and sensitize CSCs.
• The differentiation approach using DR antagonists enhances CSC sensitivity to conventional chemotherapeutics.

Conclusions:

• Targeting CSCs is a promising strategy for overcoming cancer drug resistance.
• Antipsychotic DR antagonists represent a novel class of drugs with potential in cancer treatment.
• Further research into DR antagonists could lead to more effective CSC-targeting therapies.